SHORT-TERM TREATMENT OF RATS WITH HIGH-DOSE 1,25-DIHYDROXYVITAMIN D-3STIMULATES BONE-FORMATION AND INCREASES THE NUMBER OF OSTEOBLAST PRECURSOR CELLS IN BONE-MARROW
Rg. Erben et al., SHORT-TERM TREATMENT OF RATS WITH HIGH-DOSE 1,25-DIHYDROXYVITAMIN D-3STIMULATES BONE-FORMATION AND INCREASES THE NUMBER OF OSTEOBLAST PRECURSOR CELLS IN BONE-MARROW, Endocrinology, 138(11), 1997, pp. 4629-4635
Using an experimental rat model, this study was undertaken to assess t
he effects of a short-term application of high dose 1,25-dihydroxyvita
min D-3 [1,25-(OH)(2)D-3] on calcium homeostasis, cancellous bone form
ation, and numbers of osteoblast precursors in ex vivo bone marrow cul
tures. For Exp 1 and 2, 6-month-old female rats ware sc injected with
either 0.2 mu g 1,25-(OH)(2)D-3/kg.day or vehicle on days 1, 2, and 3
of the studies. Serum calcium and urinary excretion of calcium were mo
nitored for 12 days in Exp 1. In Exp 2 the rats were ip labeled with f
ive different fluorochromes on days 0, 5, 10, 15, and 20, respectively
. Half of the rats in each group were killed on day 7, the rest of the
rats were killed on day 24, and the first lumbar vertebrae were proce
ssed for histomorphometry. In Exp 3, 0.2 mu g 1,25-(OH)(2)D-3/kg BW or
vehicle was sc administered to 6-month-old male rats on days 1, 2, an
d 3, and the number of colony-forming units with the ability to expres
s alkaline phosphatase, to calcify, and/or to synthesize collagen were
enumerated sequentially on days 4, 6, 8, 10, 12, and 14 in bone marro
w cultures. Short-term 1,25-(OH)(2)D-3 treatment resulted in increased
values for serum and urinary calcium during the treatment phase in Ex
p 1, depressed osteoclast numbers and strongly elevated osteoblast per
imeter by day 7, and stimulated mineral apposition rate and bone forma
tion rate in the interval between days 5-15 of Exp 2. Moreover, 1,25-(
OH)(2)D-3 administration to rats significantly enhanced the number of
mesenchymal precursor cells in bone marrow with the ability to differe
ntiate into an osteoblastic phenotype in ex vivo bone marrow cultures
on day 4 of Exp 3. These studies provide evidence that short-term 1,25
-(OH)(2)D-3 treatment creates new bone remodeling units and augments o
steoblast recruitment and osteoblast team performance in rat cancellou
s bone.